<DOC>
	<DOCNO>NCT02749448</DOCNO>
	<brief_summary>Background : Sulfur mustard ( SM ) potent alkylating agent target several organ , especially lung tissue . SM exposure lead serious change morphological structure airway system , associate chronic obstructive pulmonary deficiency follow exposure SM . With extensive progress achievement tissue repair stem cell therapy , consideration lung tissue increase due high prevalence pulmonary problem . Several factor selection cell type , require condition growth proliferation stem cell , process enter body repair damage lung tissue consider important problem issue . Accumulating study , animal human mesenchymal stem cell ( MSC ) support hypothesis therapeutic effect cell various disorder . In study investigator aim evaluate safety potential efficacy systemic MSC administration treatment chronic lung injury SM-exposed patient . Methods : Patients receive 100 million MSC cell every two month three injection within 6 month . After injection , parameter include safety , pulmonary function test ( PFT ) , quality-of-life indicator , 6 minute walk test ( 6MWT ) , expression inflammation oxidative stress gene evaluate .</brief_summary>
	<brief_title>Mesenchymal Stem Cells Therapy Treatment Airway Remodeling Mustard Patients</brief_title>
	<detailed_description>Patients selection : In clinical trial , investigator consider therapeutic effect MSCs SM-exposed male patients.Patients , document encounter SM Iran-Iraq war . The patient sign informed consent study . They select accord follow criterion : ( ) severity lung injury range moderate 50 &lt; forced expiratory volume 1 second ( FEV1 ) &lt; 65 severe 40 &lt; FEV1 &lt; 50 ; ( b ) absence contraindication spirometry ( hemoptysis , cerebral arterial aneurysm aortic , pulmonary embolism , uncontrolled blood pressure , recent pneumothorax , doubt surgery/thoracic recent , recent stroke ) ; ( c ) coagulation . The exclusion criterion selection process follow : ( ) participate another study time ; ( b ) smoking habitat ; ( c ) existence pneumonia study ; ( ) incidence transfusion reaction ; ( e ) underlying disease ( cardiovascular disease , hypertension , diabetes ) . Isolation culture adipose derive stem cell : 200mL abdominal adipose tissue obtain local anesthesia liposuction aspirate protocol . The lipoaspirate wash PBS remove tissue debris . 100mL PBS contain 0.1 % w/v collagenase A type I add isolated tissue incubate 37ºC 60 minute . Collagenase activity neutralize use MEM medium along 10 % fetal bovine serum . Cell pellet resuspend culture medium centrifugation 2000rpm 10 min , transferred culture flasks 72 h 37ºC 5 % CO2 condition . The culture medium flask change every 3 day , cell passaged two time . Flow cytometry analysis : To analyze cell surface antigen expression , 5×105 fresh cell third passage harvest trypsin-EDTA . Cells centrifuge 100 g 1 min , resuspend stain buffer ( PBS , 2 % FBS ) incubate ice 10 minute . Trypsin neutralize centrifuge isolated cell wash twice PBS finally resuspend stain buffer . Cells incubate dark environment 30 minute . After incubation , cell label anti-human monoclonal antibody ( MAbs ) conjugate fluorochrome . These antibody follow : anti-CD90-fluorescein isothiocyanate ( FITC ) , CD73-phycoerythrin ( PE ) , CD11b-FITC , CD34-FITC , CD44-FITC , CD45-PE , CD105-PE . The frequency immunolabeled cell analyze FACS Canto II flow cytometer , approximately 500,000 event assess data analyze use FlowJo software ( version 10.0 ) . Karyotype analysis abnormality detection : Standard Giemsa stain procedure perform chromosome preparation obtain 80 % confluent cell . To stop microtubule formation , cell treat Colcemid solution . The mitotic arrested cell harvest use trypsin-EDTA . The cell extract immersed 75 mmol/l KCl 30 minute laboratory temperature . Finally , obtain centrifugation . The supernatant replace fixative solution suspension spread slide microscopic examination imaging . At least , 15 metaphase spread analyze . The karyotype consider light microscope use cytovision software . Freezing Storage Adipose-derived Stem Cells : ADMSCs harvest 90 % confluence injection freezing . To collect cell , culture medium remove replace sterile PBS three minute replace trypsin-EDTA solution incubate 37°C 5 minute . Complete medium ( MEM 10 % FBS ) add inactivate trypsin , centrifuge 1500 rpm 5 minute . Cell pellet resuspend cryopreservation medium ( 80 % FBS , 10 % dimethylsulfoxide 10 % MEM medium ) final concentration 5 million cell per milliliter aliquoted cryovials . The vial store −80 °C overnight transfer liquid nitrogen container long-term storage . MSCs injection Study plan : Patients receive 100×106 cell every 20 day four injection within 2 month screen 7 time . MSCs inject intravenously along 300 ml normal saline patient maximum rate 2×106 cells/min . Each infusion take approximately 30 minute complete . After injection , patient stay hospital least 6h recovery time . Efficacy MSCs treatment patient evaluate use follow parameter : pulmonary function test ( PFTs ) [ forced expiratory volume 1 second ( FEV1 ) , Forced vital capacity ( FVC ) , FEV1/FVC ] , total lung capacity body plethysmography , single-breath carbon monoxide diffuse capacity ( CO diffusion ) , exercise performance [ 6-minute walk test ( 6MWT ) ] , Borg scale dyspnea assessment ( BSDA ) , COPD Assessment Test ( CAT ) , St. George 's Respiratory Questionnaire ( SRGQ ) comprehensive safety evaluation .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<criteria>patient documentary exposure mustard gas IranIraq war disease severity follow base spirometric : moderate 50 &lt; forced expiratory volume one second ( FEV1 ) &lt; 65 severe 40 &lt; FEV1 &lt; 50 absence contraindication spirometry ( recent myocardial ischemia ( MI ) hemoptysis cerebral arterial aneurysm aortic pulmonary embolism , uncontrolled blood pressure recent pneumothorax doubt surgery/recent thoracic recent eye surgery , recent stroke nonavailability another research study time coagulation disorder smoke incidence pneumonia study incidence transfusion reaction medical condition ( cardiovascular disease , hypertension , diabetes ) visit less 2 time</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>